Molecular profile
- Sequence
- Lys-Glu-Asp (KED)
- Molecular Formula
- C15H26N4O8
- Molecular Weight
- 390.39 g/mol
- PubChem CID
- 87571363
Peptide research profile
Vesugen
Vesugen, composed of the tripeptide Lys-Glu-Asp, primarily targets the vascular system, exerting significant effects throughout the body due to the systemic importance of the vascular system in various metabolic processes. Research indicates that Vesugen can enhance the survival of neurons in the central nervous system, reduce the occurrence of atherosclerosis and restenosis to safeguard blood vessels, and promote cell…
Dosing literacy
Dosing & scaling, explained
The moderated mass amounts below are retained for comparison. Near-duplicates, mix-dependent volumes and device markings are excluded. This is educational source context—not a protocol or recommendation.
Recorded amount context
Mass amounts available for comparison
- Lower range1 mgDose
Recorded example with no verified study backing; shown for amount literacy only.
- Mid range5 mgDose
Recorded example with no verified study backing; shown for amount literacy only.
Only mcg or mg amounts are retained. The calculator derives mL, syringe units or pen clicks from the current vial strength, water volume and device.
Schedule literacy
No independently verified schedule
Evidence context
No clinical amount or schedule is inferred from this material. Source verification is pending, and every displayed amount remains educational context rather than guidance.
Research best practices
Storage, handling and interpretation
Product identity
Verify the exact compound, formulation and amount against the product label or certificate before calculation.
Storage & handling
Follow the product label, certificate and validated laboratory SOP; no universal storage assumption is applied here.
Prepared solutions
Label concentration and preparation date, use sterile technique where applicable, and follow a validated stability protocol.
Research orientation
What researchers are exploring
These themes organize the educational information currently available. Individual claims remain under source review and are not treatment claims.
- 01
Research on Vesugen
Vesugen, a neuroprotective peptide, shows promise in the field of Alzheimer’s disease and central nervous system (CNS) function.…
Evidence map
What is known—and what still needs verification
Available context is organized without assigning unsupported study models or evidence grades.
- Source review pending
Research on Vesugen
Vesugen, a neuroprotective peptide, shows promise in the field of Alzheimer’s disease and central nervous system (CNS) function. Here are some key points about Vesugen: Memory Improvement: Vesugen has demonstrated the ability to improve memory in elderly…
Recorded protocol library
Amounts recorded for Vesugen
These amount records are independent from vial strength, reconstitution volume and measuring device. A recorded source is not the same as study backing, and these values are not recommendations.
- 01
Dose · lower endpoint
1 mg
Sign in for schedule, duration and source context.
- 02
Dose · upper endpoint
5 mg
Sign in for schedule, duration and source context.
Technical reference
Identity, limitations and unknowns
Important limitations
- Individual claims and source links have not yet completed editorial verification.
- Evidence level, applicable study model, formulation, route and population remain unassigned.
Source review
1 links awaiting verification
- Source link · pmc.ncbi.nlm.nih.govVerification pending · Source review pending